Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT04653168 Completed - Healthy Clinical Trials

A Study of LY3041658 in Healthy Participants

Start date: December 7, 2020
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3041658 in healthy participants. The study will measure how the body absorbs, breaks down and gets rid of LY3041658.

NCT ID: NCT04648865 Completed - Healthy Clinical Trials

A Study of LY3537031 in Healthy Participants

Start date: December 9, 2020
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3537031 in healthy participants. The blood tests will be performed to check how much LY3537031 gets into the bloodstream, how long the body takes to eliminate it and how body handles LY3537031. Each participant will receive a single dose of LY3537031 or placebo. The study will last up to approximately 71 days for each participant, including screening.

NCT ID: NCT04645485 Completed - Healthy Clinical Trials

Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers.

SANTANA
Start date: May 12, 2020
Phase: Phase 1
Study type: Interventional

SANTANA Study is a phase 1, prospective, monocentric, open-label clinical trial involving healthy adult volunteers, with the objective to evaluate the safety and tolerability of the compressor nebulization of autologous non-hematopoietic peripheral blood stem cells (NHPBSC).

NCT ID: NCT04643340 Completed - Healthy Clinical Trials

Imaging During Subliminal Perception

Start date: March 15, 2020
Phase:
Study type: Observational

Subliminal perception of visual stimuli can be studied with functional brain imaging, e.g. with functional magnetic resonance imaging (fMRI). However, it is unclear how subliminal perception affects connectivity in the brain. Further, it is not known if real-time (rt) fMRI neurofeedback of brain areas involved in subliminal perception can lead to supra-threshold perception. For attention tasks, the investigators hypothesize that functional connectivity strength is mediated by the insular cortex during both supra-threshold and subliminal perception. Additionally, the investigators hypothesize that rt-fMRI neurofeedback training should alter neuronal and behavioral responses.

NCT ID: NCT04641312 Completed - Healthy Clinical Trials

A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes

Start date: November 25, 2020
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to investigate the safety and tolerability of the study drug LY3457263 in healthy participants and participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study has two parts (part A and B). Each part will last up to 10 weeks and may include up to either 13 (part A) or 19 (part B) visits.

NCT ID: NCT04640883 Completed - Healthy Clinical Trials

Effects of Including Sprints During Low-intensity Cycling Exercises on Performance and Muscle/Blood Characteristics

Start date: October 23, 2017
Phase: N/A
Study type: Interventional

To investigate the effects of Including 30-s sprints during low-intensity cycling exercises during a training camp on performance and muscle/blood characterisitcs in elite cyclists

NCT ID: NCT04639804 Completed - Healthy Clinical Trials

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

Start date: June 6, 2020
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the pharmacokinetic (PK) interaction between tegoprazan and non-steroidal anti-inflammatory drugs (NSAIDs) after given each alone and in their combination in healthy male adults.

NCT ID: NCT04634942 Completed - Healthy Clinical Trials

A Comparison of Two Different Methods to Reduce Intramusculer Injection Pain

Start date: February 25, 2010
Phase: N/A
Study type: Interventional

When the literature is reviewed, there are few studies evaluating cold spray or ShotBlocker in reducing pain associated with IM injection. Studies have shown that these applications are mostly used in children during vaccination or intravenous interventions. These methods are less commonly used on adults. Both methods without side effects are important in terms of being cheap, easy to use and reusable. As a result of the researches, these methods can provide a more comfortable injection experience and provide evidence for pain management, especially in adults sensitive to pain. The aim of the study is to use it to reduce pain associated with IM injection in adults. To evaluate the effect of cold spray and ShotBlocker applications on pain.

NCT ID: NCT04634812 Completed - Healthy Clinical Trials

Mass Balance Study of KBP-5074 in Healthy Male Subjects

Start date: December 3, 2020
Phase: Phase 1
Study type: Interventional

This is a Phase 1, open-label, nonrandomized, single-dose mass balance and metabolite identification study in healthy male subjects.

NCT ID: NCT04631562 Completed - Healthy Clinical Trials

Study of ALXN1820 in Healthy Adult Participants

Start date: January 8, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blind, placebo-controlled single and multiple ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of ALXN1820 administered subcutaneously (SC) (ALXN1820 SC) and intravenously (IV) (ALXN1820 IV).